journal article·2021-01-08Open access

Antimicrobial Peptides Grafted onto a Plasma Polymer Interlayer Platform: Performance upon Extended Bacterial Challenge

Stefani S. Griesser, Marek Jasieniak, Krasimir Vasilev, Hans J. Griesser

Coatings· Volume 11· Issue 1

Abstract

To combat infections on biomedical devices, antimicrobial coatings have attracted considerable attention, including coatings comprising naturally occurring antimicrobial peptides (AMPs). In this study the aim was to explore performance upon extended challenge by bacteria growing in media above samples. The AMPs LL37, Magainin 2, and Parasin 1 were selected on the basis of well-known membrane disruption activity in solution and were covalently grafted onto a plasma polymer platform, which enables application of this multilayer coating strategy to a wide range of biomaterials. Detailed surface analyses were performed to verify the intended outcomes of the coating sequence. Samples were challenged by incubation in bacterial growth media for 5 and 20 h. Compared with the control plasma polymer surface, all three grafted AMP coatings showed considerable reductions in bacterial colonization even at the high bacterial challenge of initial seeding at 1 × 107 CFU, but there were increasing numbers of dead bacteria attached to the surface. All three grafted AMP coatings were found to be non-toxic to primary fibroblasts. These coatings thus could be useful to produce antibacterial surface coatings for biomaterials, though possible consequences arising from the presence of dead bacteria need to be studied further, and compared to non-fouling coatings that avoid attachment of dead bacteria.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Antimicrobial agents and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Future Industries Institute, University of South Australia, Mawson Lakes, SA 5095, Australia

Funding

NHMRC · CRC for Wound Management Innovation

References (50)

Show source-provided references
1. Mesh infection and hernia repair: A review10.1089/sur.2015.078 ↗
2. Device infections in implantable cardioverter defibrillators versus permanent pacemakers: A systematic review and meta-analysis10.1111/jce.13932 ↗
3. Ureteral stent-associated infection and sepsis: Pathogenesis and prevention: A review10.1080/08927014.2018.1562549 ↗
4. Bacterial adherence and biofilm formation on medical implants: A review10.1177/0954411914556137 ↗
5. A review of bacterial biofilms and their role in device-associated infection10.1071/HI12059 ↗
6. Antibacterial surfaces for biomedical devices10.1586/erd.09.36 ↗
7. Antibacterial surfaces and coatings produced by plasma techniques10.1002/ppap.201100097 ↗
8. A review of the biomaterials technologies for infection-resistant surfaces10.1016/j.biomaterials.2013.07.089 ↗
9. Review of titanium surface modification techniques and coatings for antibacterial applications10.1016/j.actbio.2018.10.036 ↗
10. Antimicrobial peptides–promising alternatives to conventional antibiotics
11. Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria?10.1038/nrmicro1098 ↗
12. Action of antimicrobial peptides against bacterial biofilms10.3390/ma11122468 ↗
13. The value of antimicrobial peptides in the age of resistance10.1016/S1473-3099(20)30327-3 ↗
14. Reassessing the host defense peptide landscape10.3389/fchem.2019.00043 ↗
15. Strategies in Translating the Therapeutic Potentials of Host Defense Peptides10.3389/fimmu.2020.00983 ↗
16. Real-time attack of LL-37 on single Bacillus subtilis cells10.1016/j.bbamem.2013.02.011 ↗
17. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces10.1016/j.actbio.2010.11.005 ↗
18. Antimicrobial peptides: Successes, challenges and unanswered questions10.1007/s00232-011-9343-0 ↗
19. Mechanism of action of surface immobilized antimicrobial peptides against Pseudomonas aeruginosa10.3389/fmicb.2019.03053 ↗
20. Yasir, M., Dutta, D., Kumar, N., and Willcox, M.D. (2020). Interaction of the surface bound antimicrobial peptides melimine and Mel4 with Staphylococcus aureus. Biofouling.10.1080/08927014.2020.1843638 ↗
21. Engineered chimeric peptides as antimicrobial surface coating agents toward infection-free implants10.1021/acsami.5b03697 ↗
22. Antimicrobial peptides in biomedical device manufacturing10.3389/fchem.2017.00063 ↗
23. Utilization of antimicrobial peptides, analogues and mimics in creating antimicrobial surfaces and bio-materials10.1016/j.bej.2019.107237 ↗
24. Strategies for antimicrobial peptide coatings on medical devices: A review and regulatory science perspective
25. Plasma methods for the generation of chemically reactive surfaces for biomolecule immobilization and cell colonization—A review10.1002/ppap.200600021 ↗
26. Substrate influence on the initial growth phase of plasma-deposited polymer films10.1039/b904367e ↗
27. Early stages of growth of plasma polymer coatings deposited from nitrogen-and oxygen-containing monomers10.1002/ppap.201000030 ↗
28. Functional polymers as nanoscopic building blocks10.1016/S0928-4931(02)00256-4 ↗
29. Small scale reactor for plasma processing of moving substrate web10.1016/0042-207X(89)90272-8 ↗
30. Functionality of proteins bound to plasma polymer surfaces10.1021/am300128n ↗
31. Briggs, D. (1998). Surface Analysis of Polymers by XPS and Static SIMS, Cambridge University Press.10.1017/CBO9780511525261 ↗
32. Riviere, J.P., and Myhra, S. (2009). Surface Analysis of Biomaterials. Handbook of Surface and Interface Analysis, CRC Press. [2nd ed.].10.1201/9781420007800 ↗
33. MacNeil, S., Shepherd, J., and Smith, L. (2011). Production of tissue-engineered skin and oral mucosa for clinical and experimental use. 3D Cell Culture, Springer.10.1007/978-1-60761-984-0_9 ↗
34. Immobilized streptavidin gradients as bioconjugation platforms10.1021/la204714p ↗
35. Biomedical surface science: Foundations to frontiers10.1016/S0039-6028(01)01587-4 ↗
36. Characterization of Adsorbed Protein Films by Time-of-Flight Secondary Ion Mass Spectrometry with Principal Component Analysis10.1021/la001209t ↗
37. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb10.1016/j.peptides.2012.01.015 ↗
38. Evaluation of magainin I interactions with lipid membranes: An optical and electrochemical study10.1016/j.chemphyslip.2012.05.002 ↗
39. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity10.1021/bi0256983 ↗
40. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii10.1111/j.1469-0691.2011.03581.x ↗
41. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3
42. LL-37, the only human member of the cathelicidin family of antimicrobial peptides10.1016/j.bbamem.2006.03.030 ↗
43. Structure–activity relations of parasin I, a histone H2A-derived antimicrobial peptide10.1016/j.peptides.2008.02.019 ↗
44. Investigating the nucleic acid interactions and antimicrobial mechanism of buforin II10.1016/j.febslet.2008.04.036 ↗
45. Surface-grafted antimicrobial drugs: Possible misinterpretation of mechanism of action10.1116/1.5050043 ↗
46. Mimicry of antimicrobial host-defense peptides by random copolymers10.1021/ja077288d ↗
47. Antibiofouling properties of plasma-deposited oxazoline-based thin films10.1021/acsami.6b00330 ↗
48. Covalent attachment of poly (ethylene glycol) to surfaces, critical for reducing bacterial adhesion10.1021/la034032m ↗
49. Reduced medical infection related bacterial strains adhesion on bioactive RGD modified titanium surfaces: A first step toward cell selective surfaces10.1002/jbm.a.31323 ↗
50. Antibacterial performance of polydopamine-modified polymer surfaces containing passive and active components10.1021/am200978h ↗